MIRA Pharmaceuticals (NASDAQ:MIRA) | WebDisclosure

Basculer en Français

10135	Companies
207993	Keywords
138063	Articles
110210	Press releases

Home
Companies
MIRA Pharmaceuticals

PRESS RELEASE

published on 08/19/2025 at 14:30, 7 months 12 days ago

MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
MIRA Pharmaceuticals, Inc. announces successful completion of Phase 1 Single Ascending Dose trial for oral Ketamir-2, preparing for U.S. Phase 2a trial in Q4 2025

Clinical Trial Phase 1 MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain
BRIEF

published on 08/12/2025 at 14:35, 7 months 19 days ago

MIRA Pharmaceuticals développe le kétamir-2 pour le traitement de la douleur neuropathique

Essais Cliniques Croissance Du Marché Médicaments Ketamir-2 Douleur Neuropathique
BRIEF

published on 08/12/2025 at 14:35, 7 months 19 days ago

MIRA Pharmaceuticals Advances Ketamir-2 for Neuropathic Pain Treatment

Pharmaceuticals Clinical Trials Market Growth Ketamir-2 Neuropathic Pain
PRESS RELEASE

published on 08/12/2025 at 14:30, 7 months 19 days ago

MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin
MIRA Pharmaceuticals announces the acceptance of a manuscript in Frontiers in Pharmacology detailing Ketamir-2's efficacy in neuropathic pain, supporting Phase 2a trials by 2025

Clinical Trials MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain Pharmacology
BRIEF

published on 07/30/2025 at 13:35, 8 months 1 day ago

Le kétamir-2 topique de MIRA Pharmaceuticals est comparable à la morphine injectée dans une étude sur la douleur

Soulagement De La Douleur Étude Préclinique Kétamir-2 Topique Comparaison De La Morphine Traitement Localisé
BRIEF

published on 07/30/2025 at 13:35, 8 months 1 day ago

MIRA Pharmaceuticals' Topical Ketamir-2 Matches Injected Morphine in Pain Study

Preclinical Study Pain Relief Topical Ketamir-2 Morphine Comparison Localized Treatment
PRESS RELEASE

published on 07/30/2025 at 13:30, 8 months 1 day ago

MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study
MIRA Pharmaceuticals announces new preclinical data showing topical Ketamir-2 provides effective pain relief comparable to injected morphine in animal models. The treatment has potential for both centralized and localized pain pathways

Preclinical Data MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain Topical Pain Relief
BRIEF

published on 07/29/2025 at 13:35, 8 months 2 days ago

MIRA Pharmaceuticals reçoit le feu vert de la FDA pour les essais du kétamir-2

Autorisation De La FDA Expansion Stratégique Ketamir-2 Douleur Neuropathique Essai De Phase 1
BRIEF

published on 07/29/2025 at 13:35, 8 months 2 days ago

MIRA Pharmaceuticals Receives FDA Green Light for Ketamir-2 Trials

FDA Clearance Phase 1 Trial Strategic Expansion Ketamir-2 Neuropathic Pain
PRESS RELEASE

published on 07/29/2025 at 13:30, 8 months 2 days ago

MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain
MIRA Pharmaceuticals advances non-opioid oral drug Ketamir-2 for neuropathic pain, clears FDA IND for Phase 2a, demonstrates potent effects in preclinical studies

FDA Preclinical Studies MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain

Accesswire

Published on 04/01/2026 at 04:40, 3 hours 6 minutes ago

Closing Of Non-Brokered Private Placement
Published on 04/01/2026 at 04:06, 3 hours 40 minutes ago

Jaguar Mining Reports Financial Results for the Fourth Quarter and Full Year 2025
Published on 04/01/2026 at 03:57, 3 hours 49 minutes ago

NXT Energy Solutions Announces 2025 Year-End Results
Published on 04/01/2026 at 03:10, 4 hours 36 minutes ago

Jaguar Mining Reports Updated Significant 49% Increase in Mineral Reserves at Pilar Mine, Reinforcing Long Term Growth Strategy
Published on 04/01/2026 at 01:40, 6 hours 6 minutes ago

Thunder Rock Capital Serves as Exclusive Financial Advisor in Crown Reserve Acquisition Corp. I's Proposed $1.0 Billion Business Combination with Carvix, Inc.

View all ACCESSWIRE

EQS Group

Published on 04/01/2026 at 07:30, 16 minutes ago

Nordex Group receives 35 MW order for wind farm in the Sauerland region in Germany
Published on 04/01/2026 at 07:30, 16 minutes ago

SFC Energy AG secures follow-up order of approximately CAD 3.5 million from Canadian oil and gas producer
Published on 04/01/2026 at 07:30, 16 minutes ago

Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer
Published on 04/01/2026 at 07:10, 36 minutes ago

Adler Group S.A. concludes 2025 within its guidance, demonstrating strong performance in the rental business and progress with development disposals
Published on 04/01/2026 at 07:05, 41 minutes ago

Reju Secures €135 Million in Dutch NIKI Funding for Industrial-Scale Textile-to-Textile Regeneration Hub at Chemelot Industrial Park, the Netherlands

Les Echos

Published on 03/31/2026 at 20:08, 11 hours 38 minutes ago

SMTPC - Communiqué sur les résultats annuels 2025
Published on 03/31/2026 at 19:05, 12 hours 41 minutes ago

SFPI GROUP: implementation of a new liquidity contract
Published on 03/31/2026 at 19:05, 12 hours 41 minutes ago

Groupe SFPI : mise en oeuvre d'un nouveau contrat de liquidité
Published on 03/31/2026 at 19:00, 12 hours 46 minutes ago

COGRA : Transfert du contrat de liquidité chez TSAF
Published on 03/31/2026 at 18:34, 13 hours 12 minutes ago

Damartex / Transfert du contrat de liquidité auprès du Crédit Industriel et Commercial

View all LES ECHOS COMFI WIRE